Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More

Precipio: Ron Andrews

Precipio has announced that Ron Andrews has joined the company's board of directors. In addition to currently serving as CEO of molecular diagnostics firm OncoCyte, Andrews' past experiences include a term as CEO of Roche Molecular, president of the genetic science division at Thermo Fisher Scientific, president of the medical sciences venture at Life Technologies, and CEO of Clarient.


ERS Genomics: Jon Kratochvil

ERS Genomics has appointed Jon Kratochvil as vice president for business development and licensing for North America. Kratochvil previously served as director of business development and licensing at MilliporeSigma, where he was responsible for global development opportunities for the company's gene editing and novel modalities technologies. He has also previously served as business development director for Washington University, and as licensing manager and competitive intelligence analyst for Abbott Laboratories' diagnostics division.


Omniome: Thomas O'Lenic

Sequencing firm Omniome has appointed Thomas O'Lenic as chief commercial officer. O'Lenic previously held commercial, general manager, and executive leadership positions with Advanced Cell Diagnostics (now part of Bio-Techne); IntegenX (now part of Thermo Fisher Scientific); Molecular Devices (a Danaher company); PerSeptive Biosystems, Millipore, and FreeSlate.


PierianDx: Lindsay Mateo

PierianDx, which specializes in cancer informatics for diagnostics and targeted therapies, has appointed Lindsay Mateo as chief business officer. Mateo previously served as head of commercial operations and later as vice president and head of life sciences at Tempus. She has also led commercial teams at Navican, an Intermountain Healthcare Company; and Genoptix, now part of NeoGenomics.


For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.